0001062993-23-019512.txt : 20231018
0001062993-23-019512.hdr.sgml : 20231018
20231018083629
ACCESSION NUMBER: 0001062993-23-019512
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231018
DATE AS OF CHANGE: 20231018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wagner Joseph P
CENTRAL INDEX KEY: 0001996725
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36581
FILM NUMBER: 231330989
MAIL ADDRESS:
STREET 1: 320 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Notable Labs, Ltd.
CENTRAL INDEX KEY: 0001603207
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 320 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 415-851-2410
MAIL ADDRESS:
STREET 1: 320 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: Vascular Biogenics Ltd.
DATE OF NAME CHANGE: 20140320
3
1
form3.xml
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
X0206
3
2023-10-16
0
0001603207
Notable Labs, Ltd.
NTBL
0001996725
Wagner Joseph P
C/O NOTABLE LABS, LTD.
320 HATCH DRIVE
FOSTER CITY
CA
94404
0
1
0
0
Chief Scientific Officer
Ordinary Shares
0
D
Stock Option
24.17
2030-07-05
Ordinary Shares
20174
D
Stock Option
24.64
2031-09-26
Ordinary Shares
3145
D
(1) This stock option award was granted July 6, 2020, and vests in equal installments on a monthly basis of a four-year period beginning on June 15, 2020 and ending June 15, 2024, subject to a 1-year cliff, assuming continued employment through the applicable vesting date.
(2) This stock option award was granted September 27, 2021, and vests in equal installments on a monthly basis of a four-year period beginning on September 27, 2021 and ending September 27, 2025, subject to a 1-year cliff, assuming continued employment through the applicable vesting date.
/s/ Joseph P. Wagner
2023-10-17
EX-24
2
exhibit24.htm
POWER OF ATTORNEY
Exhibit 24
Exhibit 24